Niagen Bioscience, Inc. (NAGE)
NASDAQ: NAGE · Real-Time Price · USD
9.90
+0.08 (0.81%)
At close: Aug 29, 2025, 4:00 PM
9.94
+0.04 (0.40%)
After-hours: Aug 29, 2025, 7:09 PM EDT

Niagen Bioscience Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
791406108125256297
Upgrade
Market Cap Growth
450.37%277.18%-14.15%-50.96%-14.02%15.84%
Upgrade
Enterprise Value
73437785117226284
Upgrade
Last Close Price
9.905.301.431.683.744.80
Upgrade
PE Ratio
46.0047.50----
Upgrade
Forward PE
66.0050.28----
Upgrade
PS Ratio
6.604.081.291.743.795.02
Upgrade
PB Ratio
12.308.813.784.378.0618.11
Upgrade
P/TBV Ratio
12.388.883.854.488.2919.39
Upgrade
P/FCF Ratio
37.8033.9915.45---
Upgrade
P/OCF Ratio
37.3033.5415.13---
Upgrade
EV/Sales Ratio
6.313.781.011.623.354.79
Upgrade
EV/EBITDA Ratio
42.0744.12----
Upgrade
EV/EBIT Ratio
44.0448.76----
Upgrade
EV/FCF Ratio
35.0731.5412.17---
Upgrade
Debt / Equity Ratio
0.050.060.120.150.150.10
Upgrade
Debt / EBITDA Ratio
0.180.27----
Upgrade
Debt / FCF Ratio
0.160.220.47---
Upgrade
Asset Turnover
1.601.621.531.291.401.51
Upgrade
Inventory Turnover
3.273.212.252.072.052.07
Upgrade
Quick Ratio
3.162.961.571.611.891.17
Upgrade
Current Ratio
3.883.572.402.612.781.96
Upgrade
Return on Equity (ROE)
37.36%22.94%-17.29%-54.77%-112.68%-108.09%
Upgrade
Return on Assets (ROA)
14.31%7.84%-6.42%-20.81%-35.18%-31.57%
Upgrade
Return on Capital (ROIC)
20.56%12.00%-10.82%-33.57%-62.10%-61.70%
Upgrade
Return on Capital Employed (ROCE)
24.10%15.40%----
Upgrade
Earnings Yield
2.24%2.10%-4.59%-13.19%-10.61%-6.70%
Upgrade
FCF Yield
2.65%2.94%6.47%-12.31%-9.61%-3.60%
Upgrade
Buyback Yield / Dilution
-10.13%-4.19%-7.54%-3.79%-10.02%-7.03%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q